OLIPOP PBC, founded in 2018, is redefining the soda market by infusing health benefits into a beloved classic. Operating within the Food and Beverage and Health Care industries from its base in the United States, the company is on a bold mission to enhance consumer health through its innovative product line. Unlike traditional sodas, OLIPOP's beverages integrate functional ingredients aimed at supporting the microbiome and digestive health.
With availability in over 65,000 retailers nationwide, OLIPOP is experiencing significant market traction. This growth is underscored by a successful funding round; the company secured a $30.00M Series B investment on 01 February 2022 from a diverse group of investors, including Monogram Capital Partners, Paul Klein, Nick Tran, Patrick Schwarzenegger, Jay Livingston, Rocana Venture Partners, Rupert Lincoln, Adam Eskin, Devon Levesque, and Marianna Hewitt. This strong financial backing positions OLIPOP for continued expansion within an increasingly health-conscious market.